查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1550056

抛弃式泌尿失禁用品市场:全球产业分析，规模，占有率，成长，趋势，预测，2024年～2031年

Disposable Incontinence Products Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 204 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球一次性失禁产品市场的详细研究报告。该报告提供了对市场结构的全面了解，并对关键市场动态进行了详细评估，包括推动因素、趋势、机会和挑战。

主要的洞察

  • 一次性失禁产品市场规模（2022 年）：1,350 万美元
  • 预测市场规模（2024 年）：2,210 万美元
  • 全球市场成长率（2022-2024 年复合年增长率）：7.3%

一次失禁产品市场：研究范围

一次性失禁产品对于有膀胱和肠道控制问题的人来说是必不可少的，可以提供舒适感并保持卫生。这些产品广泛用于医疗机构、家庭护理和老年人。市场提供多种产品，包括防护性失禁服装、成人尿布和护垫，这些产品易于穿着、易于处理且具有成本效益。市场成长的驱动力是肾臟疾病、肾功能损害的盛行率上升以及护理和卫生意识的提高。

推动市场成长的因素：

全球一次性失禁产品市场由几个关键因素推动，包括由于个人护理和卫生意识的提高而越来越多地采用这些产品。导致大便失禁的腹泻、肠道疾病和神经损伤患者数量的增加也促进了市场的成长。此外，老化也是一个主要因素，越来越多的老年人出现失禁，增加了对这些产品的需求。一次性产品和导管所用材料的技术进步将进一步刺激市场扩张。

市场阻碍因素：

虽然预计会成长，但一次性失禁用品市场仍面临一些挑战。与优质失禁产品相关的高成本以及与处置这些产品相关的环境问题可能会阻碍市场成长。此外，某些地区的文化偏见和缺乏意识可能会抑制市场渗透率和采用率。

市场机会：

一次性失禁产品市场透过创新产品的开发提供了巨大的成长机会。製造商致力于开发具有更高吸水性、防臭性和透气性的产品，以满足客户的多样化需求。慢性膀胱相关疾病盛行率的增加和老年人口的增加也为市场扩张提供了重大机会。在产品开发中采用永续和环保材料是迎合具有环保意识的消费者群体的另一个机会领域。

本报告解决的关键问题

  • 推动全球一次性失禁产品市场成长的关键因素是什么？
  • 哪些产品类型和应用正在推动各行业的需求？
  • 技术进步如何影响抛弃式失禁产品市场的竞争格局？
  • 谁是一次性失禁产品市场的主要参与者？
  • 全球一次性失禁用品市场的新趋势和未来前景是什么？

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围/分类
  • 市场定义/范围/限制

第3章 市场观点

  • 宏观经济要素
    • 促进因素
    • 阻碍因素
    • 机会分析
    • 趋势

第4章 主要内容

  • 美国FDA - 传统及抗菌性导尿管相关法规
  • 导管相关泌尿道感染预防指南
  • 美国FDA - 尿袋相关法规
  • 美国FDA - 失禁用防护衣相关法规
  • 退还情势
  • PEST分析
  • 价值链分析

第5章 全球抛弃式泌尿失禁用品市场 - 价格分析

  • 各地区价格分析:各产品类型
  • 世界平均价格分析基准

第6章 全球抛弃式泌尿失禁用品市场(金额或规模，一百万美元)分析

  • 过去的市场金额(一百万美元)分析，2019年～2023年
  • 现在及未来市场金额(一百万美元)预测，2024年～2031年
    • 前一年同期比较成长趋势分析
    • 绝对额的机会分析
    • 市场金额的比较

第7章 全球抛弃式泌尿失禁用品市场分析，各产品类型

  • 简介/主要调查结果
  • 过去的市场规模(一百万美元)的分析，各产品类型，2019年～2023年
  • 现在及未来市场规模(一百万美元)的分析与预测，各产品类型，2024年～2031年
  • 现在及未来市场规模(一百万单位)的分析与预测，各产品类型，2024年～2031年
    • 失禁保护服装类
    • 尿袋
    • 尿道导管
  • 市场魅力分析:各产品类型

第8章 全球抛弃式泌尿失禁用品市场分析，各原料

  • 简介/主要调查结果
  • 过去的市场规模(一百万美元)的分析，各原料，2019年～2023年
  • 现在及未来市场规模(一百万美元)的分析与预测，各原料，2024年～2031年
    • 塑胶
    • 棉织品
    • 超吸收剂
    • 棉纤维
    • 乳胶
  • 市场魅力分析:各原料

第9章 全球抛弃式泌尿失禁用品市场分析，各流通管道

  • 简介/主要调查结果
  • 过去的市场规模(一百万美元)的分析，各流通管道，2019年～2023年
  • 现在及未来市场规模(一百万美元)的分析与预测，各流通管道，2024年～2031年
  • 现在及未来市场规模(一百万单位)的分析与预测，各流通管道，2024年～2031年
    • 机构投资者销售
    • 零售
  • 市场魅力分析:各流通管道

第10章 全球抛弃式泌尿失禁用品市场分析，各地区

  • 简介
  • 过去的市场规模(一百万美元)的分析，各地区，2019年～2023年
  • 目前市场规模(一百万美元)的分析与预测，各地区，2024年～2031年
    • 北美
    • 南美
    • 欧洲
    • 亚洲
    • 中东·非洲
  • 市场魅力分析:各地区

第11章 北美的抛弃式泌尿失禁用品市场分析

第12章 南美的抛弃式泌尿失禁用品市场分析

第13章 欧洲的抛弃式泌尿失禁用品市场分析

第14章 亚太地区的抛弃式泌尿失禁用品市场分析

第15章 中东·非洲的抛弃式泌尿失禁用品市场分析

第16章 竞争分析

  • 竞争仪表板
  • 竞争的详细资讯
    • Svenska Cellulosa Aktiebolaget(SCA)
    • Becton, Dickinson and Company
    • ConvaTec Inc
    • PAUL HARTMANN AG
    • Medtronic
    • Unicharm Corporation
    • Kimberly-Clark Corporation
    • B. Braun Melsungen AG
    • Medline Industries, Inc
    • Theos Medical Systems, Inc.
    • Fujian Yifa Healthcare Products Co., Ltd
    • Abena Group
    • Mega Soft(Fujian)Hygiene Products Co., Ltd
    • Fujian Hengan Group Ltd
    • Ontex

第17章 所使用的前提条件与缩写

第18章 调查手法

简介目录
Product Code: PMRREP11518

Persistence Market Research has recently released a detailed report on the global disposable incontinence products market. This report provides an in-depth evaluation of critical market dynamics, including drivers, trends, opportunities, and challenges, offering a thorough understanding of the market structure.

Key Insights:

  • Disposable Incontinence Products Market Size (2022E): US$ 13.5 million
  • Projected Market Value (2024F): US$ 22.1 million
  • Global Market Growth Rate (CAGR 2022 to 2024): 7.3%

Disposable Incontinence Products Market - Report Scope:

Disposable incontinence products are essential for individuals suffering from bladder or bowel control issues, providing comfort and maintaining hygiene. These products are widely used in healthcare settings, home care, and among the geriatric population. The market offers various products, including protective incontinence garments, adult diapers, and pads, which are designed for ease of wear, disposal, and cost-effectiveness. Market growth is driven by the rising prevalence of renal diseases, nephrological injuries, and increasing awareness of care and hygiene.

Market Growth Drivers:

The global disposable incontinence products market is driven by several key factors, including the increased adoption of these products due to heightened awareness of personal care and hygiene. The growing number of patients with diarrhea, bowel disorders, and nerve damage leading to fecal incontinence also contributes to market growth. Additionally, the aging population is a significant driver, with a rising number of elderly individuals experiencing incontinence, thereby boosting the demand for these products. Technological advancements in the materials used for disposable products and catheters further stimulate market expansion.

Market Restraints:

Despite its growth prospects, the disposable incontinence products market faces several challenges. The high cost associated with premium incontinence products and the environmental concerns related to the disposal of these products may hinder market growth. Moreover, cultural stigma and lack of awareness in certain regions could restrain market penetration and adoption rates.

Market Opportunities:

The disposable incontinence products market presents substantial growth opportunities driven by the development of innovative products. Manufacturers are focusing on creating products with increased absorbency, odor control, and breathability to meet the diverse needs of customers. The increasing prevalence of chronic bladder-related diseases and the growing geriatric population also present significant opportunities for market expansion. The adoption of sustainable and eco-friendly materials in product development is another area of opportunity, catering to the environmentally conscious consumer base.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the disposable incontinence products market globally?
  • Which types of products and applications are leading the demand in various sectors?
  • How are technological advancements influencing the competitive landscape of the disposable incontinence products market?
  • Who are the key players in the disposable incontinence products market, and what strategies are they employing to enhance their market presence?
  • What are the emerging trends and future prospects in the global disposable incontinence products market?

Competitive Intelligence and Business Strategy:

Leading players in the global disposable incontinence products market focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to enhance product performance, comfort, and customer satisfaction. Collaborations with healthcare providers, retail chains, and online platforms facilitate market access and product adoption. Emphasis on eco-friendly products, sustainability, and customer-centric solutions drives growth and strengthens market positioning in the dynamic disposable incontinence products industry.

Key Companies Profiled:

  • Svenska Cellulosa Aktiebolaget (SCA)
  • Becton, Dickinson and Company
  • ConvaTec Inc
  • PAUL HARTMANN AG
  • Medtronic
  • Unicharm Corporation
  • Kimberly-Clark Corporation
  • B. Braun Melsungen AG
  • Medline Industries, Inc
  • Theos Medical Systems, Inc.
  • Fujian Yifa Healthcare Products Co., Ltd
  • Abena Group
  • Mega Soft (Fujian) Hygiene Products Co., Ltd
  • Fujian Hengan Group Ltd
  • Ontex

Disposable Incontinence Products Market Categorization

Disposable Incontinence Products Market By Material

  • Plastic
  • Cotton Fabrics
  • Super Absorbents
  • Cotton Fiber
  • Latex

Disposable Incontinence Products Market By Product Type

  • Protective Incontinence Garments
  • Urine Bags
  • Urinary Catheter

Disposable Incontinence Products Market By Distribution Channel

  • Institutional Sales
  • Retail Sales

Disposable Incontinence Products Market By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Market Outlook
  • 1.2. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market View Point

  • 3.1. Macro-Economic Factors
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity Analysis
    • 3.1.4. Trends

4. Key Inclusions

  • 4.1. U.S.FDA- Regulations for Conventional and Antimicrobial Foley Catheters
  • 4.2. Guidelines for the Prevention of Catheter associated Urinary Tract Infection
  • 4.3. U.S.FDA- Regulations for Urine bags
  • 4.4. U.S.FDA- Regulations for Protective Garments for Incontinence
  • 4.5. Reimbursement Scenario
  • 4.6. PEST Analysis
  • 4.7. Value Chain Analysis

5. Global Disposable Incontinence Products Market- Pricing Analysis

  • 5.1. Regional Pricing Analysis By Product Type
  • 5.2. Global Average Pricing Analysis Benchmark

6. Global Disposable Incontinence Products Market (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

  • 6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 6.2.1. Y-o-Y Growth Trend Analysis
    • 6.2.2. Absolute $ Opportunity Analysis
    • 6.2.3. Market Value Comparison

7. Global Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031, by Product Type

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019-2023
  • 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2024-2031
  • 7.4. Current and Future Market Volume (Mn Units) Analysis and Forecast By Product Type, 2024-2031
    • 7.4.1. Protective Incontinence Garments
      • 7.4.1.1. Cloth Adult Diaper
      • 7.4.1.2. Disposable Adult Diaper
      • 7.4.1.3. Disposable Protective Underwear
      • 7.4.1.4. Disposable Pads and Liners
        • 7.4.1.4.1. Bladder Control Pads
        • 7.4.1.4.2. Male Guards
        • 7.4.1.4.3. Incontinence Liners
      • 7.4.1.5. Belted and Beltless Under Garments
      • 7.4.1.6. Disposable Underpads/Sheet
    • 7.4.2. Urine Bags
      • 7.4.2.1. Leg Urine Bags
      • 7.4.2.2. Bedside Urine Bags
    • 7.4.3. Urinary Catheter
      • 7.4.3.1. Foley Catheter
      • 7.4.3.2. Intermittent Catheter
      • 7.4.3.3. External Catheter
  • 7.5. Market Attractiveness Analysis By Product Type

8. Global Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031, by Raw Material

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Raw Material, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Raw Material, 2024-2031
    • 8.3.1. Plastic
    • 8.3.2. Cotton Fabrics
    • 8.3.3. Super Absorbents
    • 8.3.4. Cotton Fibres
    • 8.3.5. Latex
  • 8.4. Market Attractiveness Analysis By Raw Material

9. Global Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031, by Distribution Channel

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2024-2031
  • 9.4. Current and Future Market Volume (Mn Units) Analysis and Forecast By Distribution Channel, 2024-2031
    • 9.4.1. Institutional Sales
      • 9.4.1.1. Hospitals
      • 9.4.1.2. Long Term Care Centers
      • 9.4.1.3. Nursing Facilities
    • 9.4.2. Retail Sales
      • 9.4.2.1. Pharmacy & Drug Stores
      • 9.4.2.2. Home Care
      • 9.4.2.3. Online & E Commerce
  • 9.5. Market Attractiveness Analysis By Distribution Channel

10. Global Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031, by Region Type

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. Asia
    • 10.3.5. Middle East & Africa
  • 10.4. Market Attractiveness Analysis By Region

11. North America Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Product Type
    • 11.3.3. By Raw Material
    • 11.3.4. By Distribution Channel
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Product Type
    • 11.4.3. By Raw Material
    • 11.4.4. By Distribution Channel
  • 11.5. North America Disposable Incontinence Products Market Trends

12. Latin America Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Argentina
      • 12.3.1.3. Mexico
      • 12.3.1.4. Rest of Latin America
    • 12.3.2. By Product Type
    • 12.3.3. By Raw Material
    • 12.3.4. By Distribution Channel
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product Type
    • 12.4.3. By Raw Material
    • 12.4.4. By Distribution Channel
  • 12.5. Latin America Disposable Incontinence Products Market Trends

13. Europe Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. Italy
      • 13.3.1.3. France
      • 13.3.1.4. U.K.
      • 13.3.1.5. Spain
      • 13.3.1.6. Russia
      • 13.3.1.7. Rest of Europe
    • 13.3.2. By Product Type
    • 13.3.3. By Raw Material
    • 13.3.4. By Distribution Channel
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product Type
    • 13.4.3. By Raw Material
    • 13.4.4. By Distribution Channel
  • 13.5. Europe Disposable Incontinence Products Market Trends

14. Asia Pacific Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 14.3.1. By Country
      • 14.3.1.1. Japan
      • 14.3.1.2. China
      • 14.3.1.3. India
      • 14.3.1.4. ASEAN
      • 14.3.1.5. Australia & New Zealand
      • 14.3.1.6. Rest of Asia Pacific
    • 14.3.2. By Product Type
    • 14.3.3. By Raw Material
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product Type
    • 14.4.3. By Raw Material
    • 14.4.4. By Distribution Channel
  • 14.5. APAC Disposable Incontinence Products Market Trends

15. Middle East & Africa Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 15.3.1. By Country
      • 15.3.1.1. GCC Countries
      • 15.3.1.2. South Africa
      • 15.3.1.3. North Africa
      • 15.3.1.4. Rest of MEA
    • 15.3.2. By Product Type
    • 15.3.3. By Raw Material
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product Type
    • 15.4.3. By Raw Material
    • 15.4.4. By Distribution Channel
  • 15.5. MEA Disposable Incontinence Products Market Trends

16. Competition Analysis

  • 16.1. Competition Dashboard
  • 16.2. Competition Deep Dive
    • 16.2.1. Svenska Cellulosa Aktiebolaget (SCA)
      • 16.2.1.1. Overview
      • 16.2.1.2. Drug Portfolio
      • 16.2.1.3. Profitability by Market Segments (Drug/Channel/Region)
      • 16.2.1.4. Sales Footprint
      • 16.2.1.5. Strategy Overview
        • 16.2.1.5.1. Marketing Strategy
        • 16.2.1.5.2. Drug Strategy
        • 16.2.1.5.3. Channel Strategy
    • 16.2.2. Becton, Dickinson and Company
      • 16.2.2.1. Overview
      • 16.2.2.2. Drug Portfolio
      • 16.2.2.3. Profitability by Market Segments (Drug/Channel/Region)
      • 16.2.2.4. Sales Footprint
      • 16.2.2.5. Strategy Overview
        • 16.2.2.5.1. Marketing Strategy
        • 16.2.2.5.2. Drug Strategy
        • 16.2.2.5.3. Channel Strategy
    • 16.2.3. ConvaTec Inc
      • 16.2.3.1. Overview
      • 16.2.3.2. Drug Portfolio
      • 16.2.3.3. Profitability by Market Segments (Drug/Channel/Region)
      • 16.2.3.4. Sales Footprint
      • 16.2.3.5. Strategy Overview
        • 16.2.3.5.1. Marketing Strategy
        • 16.2.3.5.2. Drug Strategy
        • 16.2.3.5.3. Channel Strategy
    • 16.2.4. PAUL HARTMANN AG
      • 16.2.4.1. Overview
      • 16.2.4.2. Drug Portfolio
      • 16.2.4.3. Profitability by Market Segments (Drug/Channel/Region)
      • 16.2.4.4. Sales Footprint
      • 16.2.4.5. Strategy Overview
        • 16.2.4.5.1. Marketing Strategy
        • 16.2.4.5.2. Drug Strategy
        • 16.2.4.5.3. Channel Strategy
    • 16.2.5. Medtronic
      • 16.2.5.1. Overview
      • 16.2.5.2. Drug Portfolio
      • 16.2.5.3. Profitability by Market Segments (Drug/Channel/Region)
      • 16.2.5.4. Sales Footprint
      • 16.2.5.5. Strategy Overview
        • 16.2.5.5.1. Marketing Strategy
        • 16.2.5.5.2. Drug Strategy
        • 16.2.5.5.3. Channel Strategy
    • 16.2.6. Unicharm Corporation
      • 16.2.6.1. Overview
      • 16.2.6.2. Drug Portfolio
      • 16.2.6.3. Profitability by Market Segments (Drug/Channel/Region)
      • 16.2.6.4. Sales Footprint
      • 16.2.6.5. Strategy Overview
        • 16.2.6.5.1. Marketing Strategy
        • 16.2.6.5.2. Drug Strategy
        • 16.2.6.5.3. Channel Strategy
    • 16.2.7. Kimberly-Clark Corporation
      • 16.2.7.1. Overview
      • 16.2.7.2. Drug Portfolio
      • 16.2.7.3. Profitability by Market Segments (Drug/Channel/Region)
      • 16.2.7.4. Sales Footprint
      • 16.2.7.5. Strategy Overview
        • 16.2.7.5.1. Marketing Strategy
        • 16.2.7.5.2. Drug Strategy
        • 16.2.7.5.3. Channel Strategy
    • 16.2.8. B. Braun Melsungen AG
      • 16.2.8.1. Overview
      • 16.2.8.2. Drug Portfolio
      • 16.2.8.3. Profitability by Market Segments (Drug/Channel/Region)
      • 16.2.8.4. Sales Footprint
      • 16.2.8.5. Strategy Overview
        • 16.2.8.5.1. Marketing Strategy
        • 16.2.8.5.2. Drug Strategy
        • 16.2.8.5.3. Channel Strategy
    • 16.2.9. Medline Industries, Inc
      • 16.2.9.1. Overview
      • 16.2.9.2. Drug Portfolio
      • 16.2.9.3. Profitability by Market Segments (Drug/Channel/Region)
      • 16.2.9.4. Sales Footprint
      • 16.2.9.5. Strategy Overview
        • 16.2.9.5.1. Marketing Strategy
        • 16.2.9.5.2. Drug Strategy
        • 16.2.9.5.3. Channel Strategy
    • 16.2.10. Theos Medical Systems, Inc.
      • 16.2.10.1. Overview
      • 16.2.10.2. Drug Portfolio
      • 16.2.10.3. Profitability by Market Segments (Drug/Channel/Region)
      • 16.2.10.4. Sales Footprint
      • 16.2.10.5. Strategy Overview
        • 16.2.10.5.1. Marketing Strategy
        • 16.2.10.5.2. Drug Strategy
        • 16.2.10.5.3. Channel Strategy
    • 16.2.11. Fujian Yifa Healthcare Products Co., Ltd
      • 16.2.11.1. Overview
      • 16.2.11.2. Drug Portfolio
      • 16.2.11.3. Profitability by Market Segments (Drug/Channel/Region)
      • 16.2.11.4. Sales Footprint
      • 16.2.11.5. Strategy Overview
        • 16.2.11.5.1. Marketing Strategy
        • 16.2.11.5.2. Drug Strategy
        • 16.2.11.5.3. Channel Strategy
    • 16.2.12. Abena Group
      • 16.2.12.1. Overview
      • 16.2.12.2. Drug Portfolio
      • 16.2.12.3. Profitability by Market Segments (Drug/Channel/Region)
      • 16.2.12.4. Sales Footprint
      • 16.2.12.5. Strategy Overview
        • 16.2.12.5.1. Marketing Strategy
        • 16.2.12.5.2. Drug Strategy
        • 16.2.12.5.3. Channel Strategy
    • 16.2.13. Mega Soft (Fujian) Hygiene Products Co., Ltd
      • 16.2.13.1. Overview
      • 16.2.13.2. Drug Portfolio
      • 16.2.13.3. Profitability by Market Segments (Drug/Channel/Region)
      • 16.2.13.4. Sales Footprint
      • 16.2.13.5. Strategy Overview
        • 16.2.13.5.1. Marketing Strategy
        • 16.2.13.5.2. Drug Strategy
        • 16.2.13.5.3. Channel Strategy
    • 16.2.14. Fujian Hengan Group Ltd
      • 16.2.14.1. Overview
      • 16.2.14.2. Drug Portfolio
      • 16.2.14.3. Profitability by Market Segments (Drug/Channel/Region)
      • 16.2.14.4. Sales Footprint
      • 16.2.14.5. Strategy Overview
        • 16.2.14.5.1. Marketing Strategy
        • 16.2.14.5.2. Drug Strategy
        • 16.2.14.5.3. Channel Strategy
    • 16.2.15. Ontex
      • 16.2.15.1. Overview
      • 16.2.15.2. Drug Portfolio
      • 16.2.15.3. Profitability by Market Segments (Drug/Channel/Region)
      • 16.2.15.4. Sales Footprint
      • 16.2.15.5. Strategy Overview
        • 16.2.15.5.1. Marketing Strategy
        • 16.2.15.5.2. Drug Strategy
        • 16.2.15.5.3. Channel Strategy

17. Assumptions and Acronyms Used

18. Research Methodology